shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells

Article metrics

Abstract

In this study, we aim to explore the effects of short hairpin RNAs (shRNAs) targeting human telomerase reverse transcriptase (hTERT) on the proliferation and apoptosis of osteosarcoma cells. After the synthesis of shRNA that target hTERT, osteosarcoma cells were assigned into three experimental groups—shRNA group, scramble group and blank group. The transcription and expressions of the hTERT gene in transfected cells were measured with quantitative real-time polymerase chain reaction and western blotting. Cell proliferation in each group was detected by Cell Counting Kit-8 assay. Cell cycle and rates of apoptosis were measured by flow cytometry. Expressions of apoptosis-related proteins, caspase-9 and caspase-3, were detected by western blotting. Telomerase activity was measured by PCR enzyme-linked immunosorbent assay. Results show that both the mRNA and protein expressions of hTERT were significantly lowered after the transfection of hTERT-shRNA. The proliferation capacity of transfected osteosarcoma MG-63, SaOS2 and U2OS cells in the shRNA group was lower than that in the blank group. We also found changes and differences in the amount of cells throughout the cell cycle. All cells in the G0/G1 phase increased in numbers, whereas the number of cells in the S phase were reduced, with elevated apoptosis rates. Expressions of apoptosis-related proteins, caspase-9 and caspase-3, were increased and telomerase activity was decreased in the transfected shRNA group (all P<0.05). Our results showed that shRNA targeting of the hTERT gene was able to inhibit cell proliferation and promote apoptosis of osteosarcoma cells by reducing the telomerase activity.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

References

  1. 1

    Ottaviani G, Jaffe N . The Epidemiology of Osteosarcoma. Springer: Berlin, 2009: 3–13.

  2. 2

    Mirabello L, Troisi RJ, Savage SA . Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009; 115: 1531–1543.

  3. 3

    Shaikh AB, Li F, Li M, He B, He X, Chen G et al. Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma. Int J Mol Sci 2016; 17: 506.

  4. 4

    Becker RG, Galia CR, Morini S, Viana CR . Immunohistochemical expression of vegf and her-2 proteins in osteosarcoma biopsies. Acta Ortop Bras 2013; 21: 233–238.

  5. 5

    Yao D, Cai GH, Chen J, Ling R, Wu SX, Li YP . Prognostic value of p53 alterations in human osteosarcoma: a meta analysis. Int J Clin Exp Pathol 2014; 7: 6725–6733.

  6. 6

    Liu AQ, Ge LY, Lu XL, Luo XL, Cai YL, Ye XQ et al. Silencing of the hTERT gene by shRNA inhibits colon cancer SW480 cell growth in vitro and in vivo. PLoS ONE 2014; 9: e107019.

  7. 7

    Sishc BJ, Nelson CB, McKenna MJ, Battaglia CL, Herndon A, Idate R et al. Telomeres and telomerase in the radiation response: implications for instability, reprograming, and carcinogenesis. Front Oncol 2015; 5: 257.

  8. 8

    Vicente-Duenas C, Romero-Camarero I, Sanchez-Garcia I . Understanding telomerase in cancer stem cell biology. Cell Cycle 2012; 11: 1479–1480.

  9. 9

    Shay JW, Wright WE . Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 2010; 584: 3819–3825.

  10. 10

    Raghunandan BN, Sanjai K, Kumaraswamy J, Papaiah L, Pandey B, Jyothi BM . Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: an immunohistochemical study. J Oral Maxillofac Pathol 2016; 20: 96–101.

  11. 11

    Tang H, Ge L, Shao W, Qiu Y, Cui D . Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro. Mol Biol Rep 2013; 40: 605–616.

  12. 12

    Li Y, Li M, Yao G, Geng N, Xie Y, Feng Y et al. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma. Cancer Gene Ther 2011; 18: 318–325.

  13. 13

    Zhang W, Xing L . RNAi gene therapy of SiHa cells via targeting human TERT induces growth inhibition and enhances radiosensitivity. Int J Oncol 2013; 43: 1228–1234.

  14. 14

    He Z, Kokkinaki M, Pant D, Gallicano GI, Dym M . Small RNA molecules in the regulation of spermatogenesis. Reproduction 2009; 137: 901–911.

  15. 15

    Cesare AJ, Reddel RR . Telomere uncapping and alternative lengthening of telomeres. Mech Ageing Dev 2008; 129: 99–108.

  16. 16

    Shay JW, Wright WE . Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005; 26: 867–874.

  17. 17

    Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL . Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy. Gynecol Oncol 2010; 116: 92–98.

  18. 18

    Liu Z, Li Q, Li K, Chen L, Li W, Hou M et al. Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells. Oncogene 2013; 32: 4203–4213.

  19. 19

    Yu L, Liu S, Zhang C, Zhang B, Simoes BM, Eyre R et al. Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity. Oncotarget 2013; 4: 2326–2338.

  20. 20

    Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF . Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest. Gynecol Oncol 2006; 100: 487–494.

  21. 21

    Li M, Gao P, Zhang J . Crosstalk between autophagy and apoptosis: potential and emerging therapeutic targets for cardiac diseases. Int J Mol Sci 2016; 17: 332.

  22. 22

    Baig S, Seevasant I, Mohamad J, Mukheem A, Huri HZ, Kamarul T . Potential of apoptotic pathway-targeted cancer therapeutic research: where do we stand? Cell Death Dis 2016; 7: e2058.

  23. 23

    Mirzayans R, Andrais B, Kumar P, Murray D . The growing complexity of cancer cell response to DNA-damaging agents: caspase 3 mediates cell death or survival? Int J Mol Sci 2016; 17: 708.

  24. 24

    Juraver-Geslin HA, Durand BC . Early development of the neural plate: new roles for apoptosis and for one of its main effectors caspase-3. Genesis 2015; 53: 203–224.

  25. 25

    Dai JJ, Niu YF, Wu CF, Zhang SH, Zhang DF . Both death receptor and mitochondria mediated apoptotic pathways participated the occurrence of apoptosis in porcine vitrified mii stage oocytes. Cryo Lett 2016; 37: 129–136.

  26. 26

    Yang L, Wu D, Luo K, Wu S, Wu P . Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. Cancer Lett 2009; 276: 180–188.

Download references

Acknowledgements

We would like to acknowledge the helpful comments on this paper received from our reviewers.

Author information

Correspondence to D-Q Li.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading